WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 46 filers reported holding WEREWOLF THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,171,973 | -17.2% | 547,651 | +18.1% | 0.00% | – |
| Q2 2023 | $1,414,937 | +17.3% | 463,914 | 0.0% | 0.00% | – |
| Q1 2023 | $1,206,176 | +31.1% | 463,914 | +3.3% | 0.00% | – |
| Q4 2022 | $920,300 | -53.1% | 448,927 | +3.1% | 0.00% | – |
| Q3 2022 | $1,963,000 | +21.2% | 435,256 | +9.9% | 0.00% | – |
| Q2 2022 | $1,620,000 | -29.5% | 396,069 | -24.1% | 0.00% | – |
| Q1 2022 | $2,297,000 | -63.4% | 522,087 | -1.0% | 0.00% | – |
| Q4 2021 | $6,284,000 | +115.1% | 527,545 | +209.8% | 0.00% | – |
| Q3 2021 | $2,921,000 | -3.3% | 170,265 | -1.7% | 0.00% | – |
| Q2 2021 | $3,020,000 | – | 173,127 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Funds, LP | 589,102 | $10,274,000 | 48.81% |
| MPM ASSET MANAGEMENT LLC | 4,284,172 | $74,716,000 | 13.89% |
| MPM BioImpact LLC | 2,388,011 | $41,647,000 | 6.84% |
| Soleus Capital Management, L.P. | 563,396 | $9,826,000 | 1.51% |
| RA Capital Management | 4,291,881 | $74,850,000 | 1.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 706,294 | $12,049,000 | 0.82% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,552,787 | $44,521,000 | 0.79% |
| Nicholas Investment Partners, LP | 294,654 | $5,139,000 | 0.32% |
| Avidity Partners Management LP | 650,265 | $11,341,000 | 0.31% |
| PFM Health Sciences, LP | 400,000 | $6,976,000 | 0.22% |